Description
Victoza Liraglutide pens
Victoza contains the active drug liraglutide, which belongs to a class of drugs called glucagon-like peptide-1 agonists, or GLP-1. It is prescribed as a liquid solution in a multi-dose, prefilled pen.
Liraglutide can also be found in Saxenda. The Food and Drug Administration approved Victoza in 2010 for adults with type 2 diabetes and extended approval to include use in children ages ten years and older with type 2 diabetes in 2019. It is the first non-insulin drug approved since 2010 for use in children with type 2 diabetes.
GLP-1 medications help to:
- Enhance insulin secretion
- Suppress glucagon secretion
- Suppress the appetite
- Promote an increase in beta cells in the pancreas
Reviews
There are no reviews yet.